LYPLA1 and renal fibrosis: Adenovirus-mediated overexpression of DHHC9 or iproniazid treatment and the deletion of APT1 in TECs or inhibition of APT1 using ML348 treatment effectively alleviated UUO- or IRI-induced renal fibrosis.